ArticleJournal of Zhejiang University. Science. B2022

HDAC inhibitor chidamide synergizes with venetoclax to inhibit the growth of diffuse large B-cell lymphoma via down-regulation of MYC, BCL2, and TP53 expression.

Cancan Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.